Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.

作者: William J Peppard , Carolyn J Johnston , Angela M Urmanski

DOI: 10.1586/14787210.6.1.83

关键词: LinezolidInfectious disease (medical specialty)Intensive care medicineTelavancinTigecyclineQuinupristin/dalfopristinDalfopristinQuinupristinMedicineIclaprim

摘要: … of future therapies, including oritavancin, telavancin, … However, infusion reactions related to impurities as well as the … , vancomycin, now free of impurities, again emerged as an important …

参考文章(123)
G.J. Noel, Clinical profile of ceftobiprole, a novel β‐lactam antibiotic Clinical Microbiology and Infection. ,vol. 13, pp. 25- 29 ,(2007) , 10.1111/J.1469-0691.2007.01725.X
H.F. Chambers, Ceftobiprole: in‐vivo profile of a bactericidal cephalosporin Clinical Microbiology and Infection. ,vol. 12, pp. 17- 22 ,(2006) , 10.1111/J.1469-0691.2006.01404.X
Christopher A. Schriever, Cristina Fernández, Keith A. Rodvold, Larry H. Danziger, Daptomycin: a novel cyclic lipopeptide antimicrobial. American Journal of Health-system Pharmacy. ,vol. 62, pp. 1145- 1158 ,(2005) , 10.1093/AJHP/62.11.1145
V. Attanasio, M. Conte, F. Faella, P. Pagliano, U. Fusco, Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin‐resistant strains Clinical Microbiology and Infection. ,vol. 12, pp. 391- 394 ,(2006) , 10.1111/J.1469-0691.2006.01352.X
Randall W. Smith, John F. Alksne, Infections complicating the use of external ventriculostomy. Journal of Neurosurgery. ,vol. 44, pp. 567- 570 ,(1976) , 10.3171/JNS.1976.44.5.0567
Pierluigi Viale, Leonardo Pagani, Francesco Cristini, Roberto Stefini, Riccardo Bergomi, Paolo Colombini, Giampiero Carosi, Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scandinavian Journal of Infectious Diseases. ,vol. 34, pp. 456- 459 ,(2002) , 10.1080/00365540110080467
T. A. Rupprecht, H.-W. Pfister, Clinical experience with linezolid for the treatment of central nervous system infections. European Journal of Neurology. ,vol. 12, pp. 536- 542 ,(2005) , 10.1111/J.1468-1331.2005.01001.X
Scott D Pope, Andrew M Roecker, Dalbavancin: a novel lipoglycopeptide antibacterial Pharmacotherapy. ,vol. 26, pp. 908- 918 ,(2006) , 10.1592/PHCO.26.7.908